GAVI Alliance: towards a lasting polio-free world

Supports introduction of inactivated polio vaccine in world’s 73 poorest countries

Nigerian child receives IPV
Nigerian child receives IPV WHO/F. Caillette

PHNOM PENH, 22 November 2013 – The GAVI Alliance is to begin providing support for the introduction of inactivated poliovirus vaccine (IPV) as part of routine immunisation programmes in the world’s 73 poorest countries, GAVI’s Board decided today at its meeting in Phnom Penh, Cambodia. This decision will enable GAVI to reach more of the hardest-to-reach children, and play a critical role in helping to complete polio eradication.

In May 2013, the World Health Assembly endorsed the new Polio Eradication & Endgame Strategic Plan 2013-2018, calling on countries to introduce at least one dose of IPV and begin the phased removal of oral polio vaccines.

Removing oral polio vaccines will eliminate the risk of vaccine-associated polio outbreaks. Introducing IPV is a critical step to manage any risks associated with this phased removal, by improving immunity and help prevent new vaccine-associated outbreaks. At the same time, it will contribute to hasten the eradication of remaining wild serotypes in the remaining endemic countries of Afghanistan, Nigeria and Pakistan.

By adding IPV to routine immunisation programmes, GAVI will help build synergies between existing polio and other childhood immunisation infrastructures and services, aiming to boost overall immunisation coverage and reach more children.

The GAVI Board has committed to support IPV for all GAVI-eligible and those graduating from GAVI support. Given the global health priority of polio eradication, the GAVI Board agreed to a number of policy exceptions for IPV, such as encouraging but not requiring countries to co-finance IPV introduction. More


Related News

   14/09/2021
Update on polio eradication efforts in Pakistan for August 2021
   14/09/2021
GPEI joins the 5-year action journey to achieve irreversible progress towards gender equality
   27/08/2021
Three polio survivors from Mozambique, Congo and Ethiopia share their experiences of living with the effects of disease, and their hope for a polio-free world.
   27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
   27/08/2021
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.